Congenital amegakaryocytic thrombocytopenia with and without clonal evolution to myelodysplastic syndrome: peripheral blood stem cell transplantation outcomes in a pediatric single-center case series
Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is the only cure for congenital amegakaryocytic thrombocytopenia (CAMT). However, transplant outcomes for patients progressing to myelodysplastic syndrome (MDS) with monosomy 7 remain largely unreported. Methods: We retrospectively analyzed five pediatric CAMT patients undergoing peripheral blood stem cell (PBSC) transplantation. All received uniform non-TBI myeloablative conditioning (busulfan, cyclophosphamide, rATG) with cyclosporine/methotrexate GVHD prophylaxis. Two had progressed to MDS with monosomy 7. Results: All five patients achieved rapid engraftment (median neutrophil 12 days, platelet 14 days) with donor chimerism > 99% at the last assessment and no primary graft failure. At a 3-year median follow-up, 80% (4/5) remain alive with sustained transfusion independence. The single mortality occurred in a patient with MDS with monosomy 7, who succumbed to grade IV hemorrhagic cystitis, in the setting of grade IV acute GVHD, at two months. Conclusion: In this small series, non-TBI myeloablative PBSC transplantation was associated with rapid engraftment and durable hematopoietic reconstitution in CAMT without MDS. In patients with pre-existing MDS/monosomy 7, outcomes were heterogeneous (one survivor, one death); given the small sample and concurrent risk factors, an independent effect of MDS/monosomy 7 cannot be established. These observations underscore the importance of early genetic diagnosis and timely HSCT referral.
Authors
- Zahra Karimizadeh (ORCID: https://orcid.org/0000-0002-9658-6354)
- Amirali Kalantari (ORCID: https://orcid.org/0009-0005-2629-1832)
- Mohammad Jahanpanah (ORCID: https://orcid.org/0009-0002-4716-8655)
- Maryam Behfar (ORCID: https://orcid.org/0000-0001-9473-3632)
- Leila Jafari (ORCID: https://orcid.org/0000-0001-6838-2963)
- Amir Ali Hamidieh (ORCID: https://orcid.org/0000-0002-8935-079X)
- Arghavan Tajalli
- Soudeh Ramezani Natanzi
- Mina Mokaram Doost Delkhah
Institutions
- Children's Medical Center (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Annals of Hematology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1007/s00277-026-07368-4
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00